Press release
Bacterial Pneumonia Market Size Projected To Reach 3.51 Billion By 2034 With A Cagr Of 8.7%
Bacterial Pneumonia Market Size
What Is the Projected Growth of the Bacterial Pneumonia Market?
The market size for bacterial pneumonia has seen impressive growth in the past few years. It's expected to increase from $2.31 billion in 2024 to $2.52 billion in 2025, following a compound annual growth rate (CAGR) of 9.0%. This upward trend during the historic period can be linked to the increased awareness of respiratory conditions, a rise in recorded bacterial infections, the aging population growth, expanded healare spending, urbanization, and escalating levels of air pollution.
The market size for bacterial pneumonia is anticipated to undergo a robust expansion in the upcoming years, reaching a value of $3.51 billion by 2029 with a compound annual growth rate (CAGR) of 8.7%. The projected growth for this period can be traced back to factors such as the rising incidence of alcohol and tobacco usage, escalated governmental efforts and financing, the growing frequency of respiratory infections, increased antibiotic resistance, broader access to healare, improved understanding of bacterial pneumonia, and the escalation in the creation of new therapeutics and vaccines. Key market movements foreseen during this period include the creation of advanced antibiotics, uptake of swift diagnostic tools, progress in vaccine technology, the advent of personalized medicine applications, incorporation of artificial intelligence in illness management, and broadened use of monoclonal antibodies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21109
What Are the Different Bacterial Pneumonia Market Segments?
The bacterial pneumonia market covered in this report is segmented -
1) ?? ????: Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP)
2) By Route Of Administration: Oral, Subcutaneous, Other Route Of Administration
3) By Treatments: Vaccines, Drugs
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Community-Acquired Pneumonia (CAP): Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila
2) By Hospital-Acquired Pneumonia (HAP): Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Enterobacter spp
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21109&type=smp
What Are the Primary Drivers Shaping the Bacterial Pneumonia Market?
The upsurge in the occurrence of respiratory illnesses is anticipated to propel the development of the bacterial pneumonia market in the future. Healare concerns related to breathing and gas exchange interruptions that impact the lungs and airway system organs and tissues are what respiratory diseases signify. Numerous elements, encompassing environmental, lifestyle, demographic, and genetic factors, lead to the upsurge in respiratory diseases' prevalence. These diseases heighten the likelihood of bacterial pneumonia through impairment of the immune system and lung tissue destruction, fostering an atmosphere conducive to bacterial infections. For instance, the Centers for Disease Control and Prevention, which is a US-based government entity, reported in March 2024 that the count of tuberculosis incidents escalated from 8,320 in 2022 to 9,615 in 2023. This represents a surge of 1,295 incidents. Hence, the escalating prevalence of respiratory diseases is stimulating the development of the bacterial pneumonia market.
Which Companies Are Leading in the Bacterial Pneumonia Market?
Major companies operating in the bacterial pneumonia market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca PLC, Novartis AG, GSK plc, bioMerieux SA, Shionogi & Co. Ltd., Wockhardt Limited., Zai Lab Limited, Innoviva Inc., Eagle Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics Inc., Nabriva Therapeutics plc., Clarametyx Biosciences Inc., Evopoint Biosciences Inc., Vaxcyte Inc., Acurx Pharmaceuticals Inc.
What Trends Are Driving Growth in The Bacterial Pneumonia Market?
The bacterial pneumonia market is characterized by leading corporations putting an emphasis on innovative vaccine technology, such as creating conjugate vaccines, to bolster immune response, enhance efficacy and offer extended protection against various bacterial strains. Conjugate vaccines work by connecting a weak antigen to a protein carrier, effectively boosting immunity. An example of this occurred in June 2024 when U.S pharmaceutical firm, Merck & Co. Inc., received approval from the U.S. Food and Drug Administration (FDA) for their Pneumococcal 21-valent Conjugate Vaccine, CAPVAXIVE. The goal of this vaccine is to block the occurrence of invasive pneumococcal disease and pneumonia, caused by varying streptococcus pneumoniae serotypes, mainly focusing on adults aged 18 and above. This product release signifies a noteworthy step in tackling bacterial pneumonia as well as other infections related to pneumococcus.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/bacterial-pneumonia-global-market-report
What Are the Top Revenue-Generating Geographies in the Bacterial Pneumonia Market?
North America was the largest region in the bacterial pneumonia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bacterial pneumonia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Bacterial Pneumonia Market?
2. What is the CAGR expected in the Bacterial Pneumonia Market?
3. What Are the Key Innovations Transforming the Bacterial Pneumonia Industry?
4. Which Region Is Leading the Bacterial Pneumonia Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Pneumonia Market Size Projected To Reach 3.51 Billion By 2034 With A Cagr Of 8.7% here
News-ID: 4069725 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Pneumonia
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
